Geode Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Buy |
|
|||||
|
2025
Q1 | $2.26M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $942K | Buy |
|
|||||
|
2024
Q2 | $910K | Buy |
|
|||||
|
2024
Q1 | $373K | Buy |
|
|||||
|
2023
Q4 | $317K | Hold |
|
|||||
|
2023
Q3 | $241K | Buy |
|
|||||
|
2023
Q2 | $232K | Buy |
|
|||||
|
2023
Q1 | $305K | Hold |
|
|||||
|
2022
Q4 | $299K | Sell |
|
|||||
|
2022
Q3 | $357K | Buy |
|
|||||
|
2022
Q2 | $314K | Buy |
|
|||||
|
2022
Q1 | $499K | Hold |
|
|||||
|
2021
Q4 | $558K | Sell |
|
|||||
|
2021
Q3 | $788K | Buy |
|
|||||
|
2021
Q2 | $985K | Buy |
|
|||||
|
2021
Q1 | $1.06M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $12K | Hold |
|
|||||
|
2020
Q2 | $5K | Hold |
|
|||||
|
2020
Q1 | $4K | Hold |
|
|||||
|
2019
Q4 | $7K | Hold |
|
|||||
|
2019
Q3 | $8K | Hold |
|
|||||
|
2019
Q2 | $12K | Buy |
|
|||||
|
2019
Q1 | $47K | Hold |
|
|||||
|
2018
Q4 | $18K | Hold |
|
|||||
|
2018
Q3 | $54K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $70K | Sell |
|
|||||
|
2016
Q4 | $84K | Buy |
|
|||||
|
2016
Q3 | $113K | Buy |
|
|||||
|
2016
Q2 | $319K | Buy |
|
|||||
|
2016
Q1 | $294 | Sell |
|
|||||
|
2015
Q4 | $458K | Buy |
|
|||||
|
2015
Q3 | $529K | Buy |
|
|||||
|
2015
Q2 | $571K | Buy |
|
|||||
|
2015
Q1 | $452K | Buy |
|
|||||
|
2014
Q4 | $554K | Buy |
|